Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Oct. 20, 2025, 09:34 UTC
  • 0
  • 1 comments

SURFACE ONCOLOGY, INC. (SURF) Files Form 10-Q for Period Ending 2022-08-03

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Oct. 20, 2025, 09:34 UTC
  • 0
  • 1 comments

United Therapeutics Corporation (UTHR) Files Form 10-Q for Period Ending 2022-08-03

Comment Full text

Evolus Inc (EOLS)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

EVOLUS, INC. (EOLS) Files Form 10-Q for Period Ending 2022-08-02

Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

RIGEL PHARMACEUTICALS INC (RIGL) Files Form 10-Q for Period Ending 2022-08-02

Comment Full text

Esperion Therapeutics Inc (ESPR)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

Esperion Therapeutics, Inc. (ESPR) Files Form 10-Q for Period Ending 2022-08-02

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

PHATHOM PHARMACEUTICALS, INC. (PHAT) Files Form 10-Q for Period Ending 2022-08-02

Comment Full text

Sage Therapeutics Inc (SAGE)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

Sage Therapeutics, Inc. (SAGE) Files Form 10-Q for Period Ending 2022-08-02

Comment Full text

Alnylam Pharmaceuticals Inc (ALNY)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Files Form 10-Q for Period Ending 2022-07-28

Comment Full text

Novocure Ltd (NVCR)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

NovoCure Limited (NVCR) Files Form 10-Q for Period Ending 2022-07-28

Comment Full text

Alkermes plc (ALKS)

  • Event
  • Oct. 20, 2025, 09:33 UTC
  • 0
  • 1 comments

Alkermes plc. (ALKS) Files Form 10-Q for Period Ending 2022-07-27

Comment Full text
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

Search

News categories

  • Technical Exchange News(10266)
  • Event(1436)
  • SEC News(174176)
  • FDA Approval(9605)
  • Company Report(721)
  • Business News(116901)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin